22. Moyamoya disease Clinical trials / Disease details
Clinical trials : 17 / Drugs : 22 - (DrugBank : 17) / Drug target genes : 33 - Drug target pathways : 45
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100050185 | 2021-08-23 | 2021-08-21 | Effect of stellate ganglion block on intracranial vascular and prognosis in patients with Moyamoya disease | Effect of stellate ganglion block on intracranial vascular and prognosis in patients with Moyamoya disease | Moyamoya disease | SGB group:Ipsilateral stellate ganglion block was performed with 0.2% ropivacaine 8ml;control group:Routine extracranial artery bypass grafting only; | The First Affiliated Hospital of Sun Yat-sen University | NULL | Pending | 12 | 65 | Both | SGB group:12;control group:12; | Phase 1 | China |